JP2016514155A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016514155A5 JP2016514155A5 JP2016502027A JP2016502027A JP2016514155A5 JP 2016514155 A5 JP2016514155 A5 JP 2016514155A5 JP 2016502027 A JP2016502027 A JP 2016502027A JP 2016502027 A JP2016502027 A JP 2016502027A JP 2016514155 A5 JP2016514155 A5 JP 2016514155A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- abca1
- microspheres
- active
- reading frame
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/826,066 US9101745B2 (en) | 2013-03-14 | 2013-03-14 | Sonochemical induction of ABCA1 expression and compositions therefor |
| US13/826,066 | 2013-03-14 | ||
| PCT/US2014/026018 WO2014160196A2 (en) | 2013-03-14 | 2014-03-13 | Sonochemical induction of abca1 expression and compositions therefor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016514155A JP2016514155A (ja) | 2016-05-19 |
| JP2016514155A5 true JP2016514155A5 (https=) | 2017-04-20 |
| JP6550039B2 JP6550039B2 (ja) | 2019-07-24 |
Family
ID=51530678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502027A Expired - Fee Related JP6550039B2 (ja) | 2013-03-14 | 2014-03-13 | Ａｂｃａ１発現の音響化学誘導およびそのための組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9101745B2 (https=) |
| EP (1) | EP2970991B1 (https=) |
| JP (1) | JP6550039B2 (https=) |
| AU (1) | AU2014244014B2 (https=) |
| CA (1) | CA2902047A1 (https=) |
| WO (1) | WO2014160196A2 (https=) |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
| US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| JPH03297475A (ja) | 1990-04-16 | 1991-12-27 | Ken Ishihara | 共振音波により薬物の放出を制御する方法 |
| ATE146073T1 (de) | 1991-03-22 | 1996-12-15 | Katsuro Tachibana | Verstärker zur ultraschalltherapie von erkrankungen sowie diesen enthaltende flüssige arzneimittelzusammensetzungen |
| CN1056124A (zh) | 1991-06-05 | 1991-11-13 | 清华大学 | 高效超声波基因导入方法 |
| BR9405798A (pt) | 1993-02-22 | 1995-12-12 | Vivorx Pharmaceuticals Inc | Métodos para liberação in vivo de material biológico e composições úteis dos mesmos |
| ES2152990T3 (es) | 1993-09-09 | 2001-02-16 | Schering Ag | Principios activos y microparticulas que contienen gases. |
| US6048903A (en) | 1994-05-03 | 2000-04-11 | Robert Toppo | Treatment for blood cholesterol with trans-resveratrol |
| US5558092A (en) | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
| US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
| US6265387B1 (en) | 1995-10-11 | 2001-07-24 | Mirus, Inc. | Process of delivering naked DNA into a hepatocyte via bile duct |
| US20010009904A1 (en) | 1997-12-30 | 2001-07-26 | Jon A. Wolff | Process of delivering a polynucleotide to a cell via the vascular system |
| US5849727A (en) | 1996-06-28 | 1998-12-15 | Board Of Regents Of The University Of Nebraska | Compositions and methods for altering the biodistribution of biological agents |
| AU732872C (en) | 1996-08-15 | 2002-02-21 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| JP2002515887A (ja) | 1996-10-19 | 2002-05-28 | クウォドラント、ヘルスケアー、（ユーケー）、リミテッド | 診断および治療における中空マイクロカプセルの使用 |
| US6120751A (en) | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| US6575956B1 (en) | 1997-12-31 | 2003-06-10 | Pharmasonics, Inc. | Methods and apparatus for uniform transcutaneous therapeutic ultrasound |
| US6066123A (en) | 1998-04-09 | 2000-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of bioavailability by use of focused energy delivery to a target tissue |
| US6135976A (en) | 1998-09-25 | 2000-10-24 | Ekos Corporation | Method, device and kit for performing gene therapy |
| WO2000042988A1 (en) | 1999-01-21 | 2000-07-27 | University Of Virginia | Method of identifying and treating inflamed tissue |
| SG121853A1 (en) * | 1999-06-18 | 2006-05-26 | Cv Therapeutics Inc | Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| US6821774B1 (en) | 1999-06-18 | 2004-11-23 | Cv Therapeutics, Inc. | Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1 |
| DE60026313D1 (de) | 1999-07-23 | 2006-04-27 | Uutech Ltd | Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes |
| JP2002145784A (ja) * | 2000-11-10 | 2002-05-22 | Ryuichi Morishita | 生物学的活性薬剤導入組成物およびその使用方法 |
| CA2452471C (en) * | 2001-07-10 | 2010-06-29 | Michael N. Davidson | Enhancement of transfection of dna into the liver |
| US7470659B2 (en) | 2001-12-07 | 2008-12-30 | The Regents Of The University Of California | Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
-
2013
- 2013-03-14 US US13/826,066 patent/US9101745B2/en active Active
-
2014
- 2014-03-13 WO PCT/US2014/026018 patent/WO2014160196A2/en not_active Ceased
- 2014-03-13 CA CA2902047A patent/CA2902047A1/en active Pending
- 2014-03-13 AU AU2014244014A patent/AU2014244014B2/en active Active
- 2014-03-13 JP JP2016502027A patent/JP6550039B2/ja not_active Expired - Fee Related
- 2014-03-13 EP EP14772576.6A patent/EP2970991B1/en active Active
-
2015
- 2015-06-30 US US14/788,259 patent/US9393328B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Entzian et al. | Drug delivery by ultrasound-responsive nanocarriers for cancer treatment | |
| Ilovitsh et al. | Low-frequency ultrasound-mediated cytokine transfection enhances T cell recruitment at local and distant tumor sites | |
| Lamichhane et al. | Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery | |
| Borden et al. | DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles | |
| US6812204B1 (en) | Delivery of an agent | |
| Cavalli et al. | Micro-and nanobubbles: a versatile non-viral platform for gene delivery | |
| Kuhn et al. | Delivery of Cas9/sgRNA ribonucleoprotein complexes via hydroxystearyl oligoamino amides | |
| Gao et al. | Ultrasound-triggered phase-transition cationic nanodroplets for enhanced gene delivery | |
| Gholap et al. | Harnessing nanovaccines for effective immunization─ a special concern on COVID-19: facts, fidelity, and future prospective | |
| KR20160110410A (ko) | 하이브리도좀, 이를 포함하는 조성물, 이의 제조 방법 및 이의 용도 | |
| US20040071664A1 (en) | Delivery of an agent | |
| CN117120028A (zh) | 使用载剂靶向递送治疗剂的组合物和方法 | |
| Wallen et al. | Exosomes as an emerging plasmid delivery vehicle for gene therapy | |
| Desai et al. | “Bioinspired” membrane-coated nanosystems in cancer theranostics: a comprehensive review | |
| MXPA02007635A (es) | Metodo para cargar un globulo rojo con un ajente. | |
| Gan et al. | Biomimetic nanoparticles with cell-membrane camouflage for rheumatoid arthritis | |
| Gorick et al. | Applications of ultrasound to stimulate therapeutic revascularization | |
| Hua et al. | Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research | |
| WO2018098315A1 (en) | Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy | |
| Sultana et al. | Advances in cell membrane-coated nanoparticles: multifunctional platforms for targeted drug delivery, precision phototherapy, and enhanced immunotherapy | |
| Chen et al. | Ultrasound-targeted microbubble destruction for cardiac gene delivery | |
| Abdessalem et al. | Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells | |
| Yin et al. | Efficient gene editing for heart disease via ELIP-based CRISPR delivery system | |
| Ma et al. | Revolutionizing rheumatoid arthritis therapy: harnessing cytomembrane biomimetic nanoparticles for novel treatment strategies | |
| EP1196143B1 (en) | Use of an electric field for sensitising red blood cells to ultrasound |